[关于预防和治疗绝经后骨质疏松症的黑激素的研究进展]
1The Fourth Clinical College of Zhejiang Chinese Medicine University, Hangzhou 310053,China.
概括
黑色素通过调节骨代谢来预防绝经后骨质疏松症 (PMOP) 是有前途的. 本综述探讨了其提高骨密度的潜力,并为PMOP提供了新的治疗策略.
科学领域:
- 内分泌学 在内分泌学.
- 骨的新陈代谢 骨的新陈代谢
- 老年学是指老年学的学科.
背景情况:
- 绝经后骨质疏松症 (PMOP) 是与雌激素缺乏相关的重大健康问题.
- 目前对PMOP的治疗有局限性,需要新的治疗途径.
- 腺激素 - - 黑激素 - - 影响昼夜节律和骨健康.
研究的目的:
- 审查黑激素在预防绝经后骨质疏松症中的作用.
- 探索黑激素作为PMOP治疗剂的潜力.
- 为未来的PMOP诊断和治疗策略提供见解.
主要方法:
- 国内和国际研究的文献综述.
- 对黑激素对骨代谢影响的研究分析.
- 综合了有关黑激素对骨质母细胞和骨质母细胞的影响的发现.
主要成果:
- 黑色素会影响骨质母细胞和骨质母细胞的产生.
- 研究表明,黑激素可以增加骨密度.
- 黑素可以改善骨质疏松症的症状.
结论:
- 黑色素为预防和治疗PMOP提供了一个有希望的途径.
- 对黑激素机制的进一步研究可能会导致创新的治疗方法.
- 黑色素可以提供一种超越传统PMOP治疗的新策略.
相关概念视频
Menopause
252
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
252
Management of Insomnia
324
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
324
Bone Disorders
4.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
4.0K
Osteoclasts in Bone Remodeling
3.2K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.2K
Bone Remodeling
38.5K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.5K
Sedatives and Hypnotics Drugs: Miscellaneous Agents
245
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
245


